Pot Menopausal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Drs Vidula and Lu review the potential impact of cardiovascular health associated with oral selective estrogen receptor degraders (SERDs) and discuss how the risk of menopausal symptoms differ between oral SERDs and other endocrine therapies.

Neelima vidulaJanice luRyan haumschildEstrogen receptors degradersEr her2 metastatic breast cancerBone healthBone metastasesBone density scanPot menopausalMenopausal symptomsEmerald study